2nd SCI/RSC Fibrosis Medicinal Chemistry Symposium

10 November 2017 09:30-17:00, London, United Kingdom


Introduction
Fibrosis disease can manifest in many areas of the body, the result of a deregulated wound healing process after injury, which can lead to high mortality. With two drugs recently reaching marketed status for IPF (Idiopathic Pulmonary Fibrosis), there is continued growth and investment to identify new treatments, including for other conditions such as liver fibrosis and diabetic nephropathy. Fibrosis has complex disease pathology and greater knowledge of mechanisms is sought. This symposium will cover drug discovery and medicinal chemistry aspects of fibrotic conditions from leading experts in the field.


The conference will be of interest to researchers, academics, students and industrialists with an interest in fibrosis disease, medicinal chemistry and drug discovery.


Programme

-An overview of liver and kidney fibrosis

Dr Fiona Oakley, University of Newcastle, UK
 
-Idiopathic pulmonary fibrosis: Impact of current treatments, limitations and opportunities

Dr Hannah Woodcock, University College London, UK
 
-αv integrin modulators for fibrosis and the profile of an αvβ6 clinical candidate

Dr Simon Macdonald, GlaxoSmithKline, UK
 
-Discovery and development of galectin-3 ligand mimetics as anti-fibrosis compounds

Prof Ulf Nilsson, Lund University, Sweden
 
-Discovery of GLPG1690: a first-in-class autotoxin inhibitor in clinical development for the treatment of idiopathic pulmonary fibrosis

Dr Nicolas Desroy, Galapagos, France
 
-Porcupine inhibitors as anti-fibrotic therapies

Dr Cliff Jones, Redx Pharma Plc, UK
 
-Cannabinoid Receptor (CB1R) based dual-target approaches for the treatment of fibrotic conditions

Dr Malliga Iyer, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, USA‚Äč


Early bird fees before Friday 29 September 2017
  • GB£80 . . . . . . . . . . . . . . . . . SCI/RSC Member 
  • GB£35 . . . . . . . . . . . . . . . . . SCI/RSC Student Member
  • GB£50 . . . . . . . . . . . . . . . . . SCI/RSC Subsidised Member
  • GB£120 . . . . . . . . . . . . . . . ..Non-Member

Standard fees after Friday 29 September 2017
  • GB£110 . . . . . . . . . . . . . . . . . SCI/RSC Member 
  • GB£50 . . . . . . . . . . . . . . . . . . SCI/RSC Student Member
  • GB£75 . . . . . . . . . . . . . . . . . . SCI/RSC Subsidised Member
  • GB£150 . . . . . . . . . . . . . . . . . Non-Member
Speakers
Sponsorship & supporting organisations
Venue
SCI

SCI, 14/15 Belgrave Square, London, SW1X 8PS, United Kingdom

Committee
Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*